Abstract: The positioning accuracy of a reconfigurable intelligent surface (RIS) assisted indoor positioning system (IPS) can be improved by developing a fingerprinting database for different RIS ...
Every engineering leader watching the agentic coding wave is eventually going to face the same question: if AI can generate production-quality code faster than any team, what does governance look like ...
The FT's sources claim that one particular 13-hour interruption in December of last year was caused by the agentic tool deciding that the best course of action was to "delete and recreate the ...
Abstract: As data management continues to evolve, mastering database manipulation has become crucial for achieving business success. This paper presents a methodology that effectively integrates GAI ...
VittoriaDB is a high-performance, embedded vector database designed for local AI development and production deployments. Built with simplicity and performance in mind, it provides a zero-configuration ...
Back in 2021, Spotify introduced "Developer Mode," a sandboxed environment where developers can test and validate their application ideas with a small group of up to 25 users. Now, the company is ...
The Government of Canada is building one strong Canadian economy, and skilled trades workers are essential to that growth. As part of this commitment, the government has doubled its investment in the ...
Applications and reference implementations demonstrating how to build AI-powered solutions with Oracle technologies. These complete, working examples showcase end-to-end implementations of AI ...
This report evaluates how physical education, physical activity and sport-related policies might contribute to the Sustainable Development Goals (SDGs), providing a baseline for measurement. It ...
Ashes of Creation is a self-proclaimed "old-school take" on the modern MMORPG, and is the product of a hugely successful $3.27 million Kickstarter back in 2017. After spending extended time in Alpha, ...
Mayo Clinic’s Chelsee Jensen, PharmD, discusses FDA policy changes, biosimilar development hurdles, denosumab lessons, and payer access strategies. Chelsee Jensen, PharmD, BCPS, senior pharmacy ...